We have completed the initial review of the mass-production release and assigned owners for the remaining actions related to trial acceptance, capability, and unresolved risks.

PCBA Engineering & NPIMass Production ReleaseB1professional

เราได้ทบทวนการ Release Mass Productionเบื้องต้นเสร็จแล้ว และกำหนด Owner สำหรับ Action ที่เหลือเกี่ยวกับ ผล Trial, Capability และความเสี่ยงที่ยังเปิดอยู่

แกะรูปประโยค

สถานการณ์ / Intent

Action update

Grammar / Pattern

present perfect + action

คำศัพท์สำคัญ

mass-production release; trial acceptance, capability, and unresolved risks

ระดับภาษา

B1 · professional

ใช้ประโยคนี้อย่างไร

Present Perfect เหมาะกับงานที่ทำเสร็จแล้วและผลยังเกี่ยวข้องกับสถานะปัจจุบัน เช่น Review เสร็จและมี Action ต่อ

พูด/เขียนได้หลายแบบ

FORMAL

Please ensure that the mass-production release is fully verified against the approved requirements for trial acceptance, capability, and unresolved risks before release.

CASUAL

Can we check the mass-production release and close the remaining points on trial acceptance, capability, and unresolved risks?

ALTERNATIVE

For the mass-production release, confirm the latest revision, the cut-in point, validation evidence, and any open risk before release.

Grammar Reference

Present Perfect for Completed Work with Current ImpactPresent Perfect สำหรับสิ่งที่ทำเสร็จและมีผลถึงปัจจุบัน · Subject + have/has + past participle Present Simple for Process FactsPresent Simple สำหรับข้อเท็จจริงและขั้นตอนงาน · Subject + base verb(s/es)Present Continuous for Current StatusPresent Continuous สำหรับสถานะที่กำลังเกิดขึ้น · Subject + am/is/are + verb-ing

แกะรูปประโยค

ใช้ประโยคนี้อย่างไร

พูด/เขียนได้หลายแบบ

Grammar Reference

ประโยคใกล้เคียง

Do not release the mass-production release until the latest revision, cut-in point, validation evidence, and open risks have been reviewed with the responsible functions.

Before the next release, verify the controls for trial acceptance, capability, and unresolved risks in the mass-production release.

The team is reviewing the controls for trial acceptance, capability, and unresolved risks as part of the mass-production release.

We found a gap in the mass-production release: one or more controls related to trial acceptance, capability, and unresolved risks do not match the approved requirement.

If the mass-production release is not closed before the next build, the unresolved points around trial acceptance, capability, and unresolved risks may create a production or quality risk.

Could you clarify how the controls for trial acceptance, capability, and unresolved risks will be verified and who will approve the mass-production release?

We would appreciate it if you could provide the latest evidence for the mass-production release, including the status of trial acceptance, capability, and unresolved risks, by 3 p.m. today.

For management review, the main open point in the mass-production release is the control of trial acceptance, capability, and unresolved risks; the immediate risk is contained, and the team is working toward final closure.